On Tuesday, March 8th, the Centers for Medicare and Medicaid Services (CMS) proposed a rule that would test a new way for Medicare Part B to pay for prescription drugs. The proposal includes value-based insurance design (V-BID) principles of discounting or eliminating cost-sharing and varying payments for drugs based on clinical effectiveness for different indicators (clinical nuance).
CMS Acting Administrator Andy Slavitt stated, “These proposals would allow us to test different ways to help Medicare beneficiaries get the right medications and right care while supporting physicians in the process. This is consistent with our focus on testing value-based care models like we have been doing with physicians and hospitals in ACOs. Models like this one can help doctors and other clinicians do what they do best: choose the medicine and treatment that keeps their patients healthy.”
Read more on V-BID in the Medicare program.
